Clinical trial
TOBY ATLAS: A Multi-Site, Non-Interventional Study of Urinary Volatile Organic Compounds
NCT07933042 is registered in ClinicalTrials.gov with Toby, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- TOBY ATLAS: A Multi-Site, Non-Interventional Study of Urinary Volatile Organic Compounds
- Lead sponsor
- Toby, Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- January 31, 2032
- Enrollment
- 30,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, cancer
Arms
As registered; 2 arms.
-
Target disease cases
Participants with a target disease established by the applicable reference standard, including participants assessed after treatment where specified.
-
Controls
Participants without the target disease for a given analysis, including healthy participants and participants with other diseases, benign conditions, or negative diagnostic work-ups.
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Clinical performance of each locked assay
Sensitivity and specificity at pre-specified thresholds, and area under the receiver operating characteristic curve, of each locked assay against the applicable reference standard in its intended-use population, using blinded validation specimens not used to develop that assay. Estimates will include 95% confidence intervals.
-
Paired comparison with available standard-of-care tests
Differences in sensitivity, specificity, and area under the receiver operating characteristic curve between each locked assay and each available standard-of-care test in the same participants, with 95% confidence intervals.
Similar trials
Same condition (Alzheimer Disease) and phase, most recent start first.
+818 more trials See the condition page